Just noticed the antimony price target for UAMY got bumped up pretty significantly. Analysts are now averaging $11.14 per share, up from $9.86 a few months back - that's a solid 12.93% increase. The range is wide though, from $9.09 to $14.18, so there's still some debate out there.

What caught my eye is the institutional activity. Over 276 funds are holding positions now, and that number grew by 34 in the last quarter alone. Two Sigma really ramped up their stake - went from 278K shares to 2.92M, basically a 90% jump. Citadel trimmed their position though, cutting down from 3.31M to 2.74M shares. Geode and Vanguard's index fund are also holding decent chunks.

The antimony price is currently sitting around $8.37, so if these analyst targets hold, there's meaningful upside potential. The put/call ratio is at 0.20, which typically signals bullish sentiment. Institutional buying has picked up 20% in total shares over the past three months, which is generally a positive sign. Fund allocation to UAMY averaged 0.05% across portfolios, up 27% from before.

Still early to say if this antimony price run continues, but the combination of upgraded targets and increased institutional ownership is definitely worth watching. The spread between current price and analyst targets suggests room to run if sentiment holds.